STAT

Democrats zero in on high drug prices in Iowa debate

Democrats heaped criticism on pharma during Tuesday’s debate, highlighting a long list of policies they say will help lower high drug prices.
Democratic presidential candidate Sen. Elizabeth Warren (D-Mass.) speaks to Sen. Bernie Sanders (I-Vt.) as former Vice President Joe Biden watches during a Democratic presidential primary debate in Des Moines, Iowa.

WASHINGTON — Until Tuesday, nearly every single Democratic primary debate has focused on the same health care issue: “Medicare for All.”

So when Democrats got the chance to talk about their plans to lower drug prices, they jumped. Candidates uniformly criticized drug companies as examples of corporate irresponsibility and outsize political influence.

Sen. Elizabeth Warren (D-Mass.), in particular, doubled down on a pledge to lower drug

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks